Hideki Fujii
About
Hideki Fujii is a scholar working on Immunology, Molecular Biology and Epidemiology.
According to data from OpenAlex, Hideki Fujii has authored 46 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Immunology, 10 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Hideki Fujii's work include Immune Cell Function and Interaction (10 papers), T-cell and Retrovirus Studies (6 papers) and Animal Disease Management and Epidemiology (6 papers). Hideki Fujii is often cited by papers focused on Immune Cell Function and Interaction (10 papers), T-cell and Retrovirus Studies (6 papers) and Animal Disease Management and Epidemiology (6 papers). Hideki Fujii collaborates with scholars based in Japan, United States and Netherlands. Hideki Fujii's co-authors include Shigeo Koyasu, Masashi Ohtani, Taketo Yamada, Tomokatsu Ikawa, Kazuyo Moro, M. Tanabe, Tsutomu Takeuchi, Hiroshi Kawamoto, Jonathan Sprent and Charles D. Surh and has published in prestigious journals such as Nature, Journal of Clinical Investigation and The Journal of Experimental Medicine.
In The Last Decade
Hideki Fujii
45 papers receiving 3.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Hideki Fujii Japan | 21 | 2.4k | 993 | 470 | 398 | 391 | 46 | 3.2k | ||
| De’Broski R. Herbert United States | 31 | 2.3k 1.0× | 713 0.7× | 417 0.9× | 548 1.4× | 495 1.3× | 80 | 4.2k | ||
| Taheri Sathaliyawala United States | 8 | 2.9k 1.2× | 1.3k 1.3× | 387 0.8× | 388 1.0× | 387 1.0× | 8 | 3.5k | ||
| Ahmed N. Hegazy Germany | 22 | 2.7k 1.1× | 600 0.6× | 291 0.6× | 610 1.5× | 289 0.7× | 44 | 3.5k | ||
| R. Lee Reinhardt United States | 27 | 4.8k 2.1× | 1.0k 1.0× | 510 1.1× | 589 1.5× | 565 1.4× | 46 | 5.9k | ||
| Damian Turner United States | 15 | 3.9k 1.6× | 1.3k 1.3× | 814 1.7× | 353 0.9× | 501 1.3× | 18 | 4.5k | ||
| Cathryn Nagler‐Anderson United States | 22 | 1.4k 0.6× | 495 0.5× | 232 0.5× | 449 1.1× | 518 1.3× | 36 | 2.8k | ||
| Dietmar M. Zaiss United Kingdom | 30 | 2.2k 0.9× | 666 0.7× | 357 0.8× | 1.0k 2.6× | 274 0.7× | 56 | 3.7k | ||
| Chiara Romagnani Germany | 39 | 4.4k 1.9× | 708 0.7× | 616 1.3× | 566 1.4× | 227 0.6× | 69 | 5.3k | ||
| Jacqueline Perrigoue United States | 16 | 1.3k 0.6× | 400 0.4× | 186 0.4× | 289 0.7× | 476 1.2× | 23 | 2.1k | ||
| Brian J. Laidlaw United States | 25 | 4.4k 1.9× | 1.3k 1.3× | 626 1.3× | 729 1.8× | 486 1.2× | 32 | 5.4k |
Countries citing papers authored by Hideki Fujii
Since
Specialization
Citations
This map shows the geographic impact of Hideki Fujii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Fujii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Fujii more than expected).
Fields of papers citing papers by Hideki Fujii
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Hideki Fujii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Fujii. The network helps show where Hideki Fujii may publish in the future.
Co-authorship network of co-authors of Hideki Fujii
This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Fujii. A scholar is included among the top collaborators of Hideki Fujii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Fujii. Hideki Fujii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Matsubara, Toshiyuki, Yuka Hiroshima, Naoto Okada, et al.. (2025). Characterization of Lachnoanaerobaculum sanguinis sp. nov., isolated from a blood culture of an acute myeloid leukemia patient with chemotherapy-related bacteremia. Anaerobe. 93. 102961–102961.
2.
Okada, Naoto, Akikazu Murakami, Masami Sato, et al.. (2022). First reported case of Lachnoanaerobaculum gingivalis bacteremia in an acute myeloid leukemia patient with oral mucositis during high dose chemotherapy. Anaerobe. 76. 102610–102610.
3.
Ishida, Yuichi, Takaharu Goto, Megumi Watanabe, et al.. (2022). 2-methacryloyloxyethyl phosphorylcholine polymer treatment prevents <i>Candida albicans</i> biofilm formation on acrylic resin. Journal of Prosthodontic Research. 67(3). 384–391.
4.
Namkoong, Ho, Makoto Ishii, Hideki Fujii, et al.. (2019). Obesity worsens the outcome of influenza virus infection associated with impaired type I interferon induction in mice. Biochemical and Biophysical Research Communications. 513(2). 405–411.
5.
Namkoong, Ho, Makoto Ishii, Hideki Fujii, et al.. (2018). Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia. PLoS Pathogens. 14(4). e1006955–e1006955.
6.
Murakami, Keiji, Hiromichi Yumoto, Kouji Hirao, et al.. (2017). Antibiofilm and Anti‐Inflammatory Activities of Houttuynia cordata Decoction for Oral Care. Evidence-based Complementary and Alternative Medicine. 2017(1). 2850947–2850947.
7.
Fujii, Hideki, Takuya Miyagi, Yoshiaki Takahashi, et al.. (2016). Heat Shock Enhances the Expression of the Human T Cell Leukemia Virus Type-I (HTLV-I) Trans-Activator (Tax) Antigen in Human HTLV-I Infected Primary and Cultured T Cells. Viruses. 8(7). 191–191.
8.
Fujii, Hideki, Mamoru Shimizu, Takuya Miyagi, et al.. (2016). A Potential of an Anti-HTLV-I gp46 Neutralizing Monoclonal Antibody (LAT-27) for Passive Immunization against Both Horizontal and Mother-to-Child Vertical Infection with Human T Cell Leukemia Virus Type-I. Viruses. 8(2). 41–41.
9.
Tanaka, Yuetsu, Yoshiaki Takahashi, Reiko Tanaka, et al.. (2014). Elimination of Human T Cell Leukemia Virus Type-1-Infected Cells by Neutralizing and Antibody-Dependent Cellular Cytotoxicity-Inducing Antibodies Against Human T Cell Leukemia Virus Type-1 Envelope gp46. AIDS Research and Human Retroviruses. 30(6). 542–552.
10.
Yasui, Fumihiko, Michinori Kohara, Masahiro Kitabatake, et al.. (2014). Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus. Virology. 454-455. 157–168.
11.
Asami, Takahiro, Makoto Ishii, Hideki Fujii, et al.. (2013). Modulation of Murine Macrophage TLR7/8-Mediated Cytokine Expression by Mesenchymal Stem Cell-Conditioned Medium. Mediators of Inflammation. 2013. 1–13.
12.
Ishii, Makoto, Ho Namkoong, Hideki Fujii, et al.. (2012). Clarithromycin Modulates Cytokine Expression Profiles In Murine Macrophages And Dendritic Cells During Influenza A Virus Infection. A5718–A5718.
13.
Enomoto, Masaru, Nobuo Negoro, Hideki Fujii, et al.. (2010). Hepatitis B-associated cryoglobulinemia and antiphospholipid antibodies. Kanzo. 51(8). 454–456.
14.
Nitta, Takeshi, Shigeo Murata, Katsuhiro Sasaki, et al.. (2010). Thymoproteasome Shapes Immunocompetent Repertoire of CD8+ T Cells. Immunity. 32(1). 29–40.
15.
Moro, Kazuyo, Taketo Yamada, M. Tanabe, et al.. (2009). Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells. Nature. 463(7280). 540–544.
16.
Hayashi, Toshiyuki, Shigenori Nagai, Hideki Fujii, et al.. (2009). Critical Roles of NK and CD8+ T Cells in Central Nervous System Listeriosis. The Journal of Immunology. 182(10). 6360–6368.
17.
Doi, Tomomitsu, Konen Obayashi, Takashi Kadowaki, Hideki Fujii, & Shigeo Koyasu. (2008). PI3K is a negative regulator of IgE production. International Immunology. 20(4). 499–508.
18.
Matsuda, Masanori, Hideki Fujii, Hiroshi Kono, & Yoshirô Matsumoto. (2001). Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer. Journal of Hepato-Biliary-Pancreatic Surgery. 8(4). 353–359.
19.
Fujii, Hideki, Riko Kitazawa, Sakan Maeda, Kosaku Mizuno, & Sohei Kitazawa. (1999). Expression of platelet-derived growth factor proteins and their receptor α and β mRNAs during fracture healing in the normal mouse. Histochemistry and Cell Biology. 112(2). 131–138.
20.
Imamura, N, Yoichiro Kusunoki, Oda K, et al.. (1989). [Aggressive natural killer cell leukemia/lymphoma--possible existence of a new clinical entity originating from the third lineage of lymphoid cells].. PubMed. 30(2). 193–201.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by De’Broski R. Herbert Breakdown of academic impact, for papers by Taheri Sathaliyawala Breakdown of academic impact, for papers by Ahmed N. Hegazy Breakdown of academic impact, for papers by R. Lee Reinhardt Breakdown of academic impact, for papers by Damian Turner Breakdown of academic impact, for papers by Cathryn Nagler‐Anderson Breakdown of academic impact, for papers by Dietmar M. Zaiss Breakdown of academic impact, for papers by Chiara Romagnani Breakdown of academic impact, for papers by Jacqueline Perrigoue Breakdown of academic impact, for papers by Brian J. Laidlaw